Effect of cytostatic drug treatment on the cell cycle phases of B16 melanoma cells.
- Kathrin Pfarr (700517)
- Corina Danciu (700518)
- Olga Arlt (700519)
- Christina Neske (700520)
- Cristina Dehelean (700521)
- Josef M. Pfeilschifter (286796)
- Heinfried H. Radeke (299766)
Publication date
March 2015
DOIAbstract
<p>Cell cycle analysis of B164A5 (A) and B16F10 (B) melanoma cells treated with 100 μM genistein (GEN), 5 μM fingolimod (FIN) or 5 μM betulin (BET) for 72 h, respectively. The quantification of cells in G0/G1, S and G2/M were analyzed using flow cytometry by PI staining after 24 h (mean ± SD, n = 4). Significance was calculated using two-way ANOVA with a Bonferroni post-test.</p
Add to ORKG